From prayer times to family vigils, everyday realities can alter how delirium presents — and how clinicians should respond.

CeriBell (NASDAQ:CBLL) outlined its recent progress and 2026 priorities at a JPMorgan MedTech event, emphasizing continued ...

Researchers are sounding the alarm on dangerous stimulant medications commonly prescribed to dementia patients in the U.S.

CeriBell Inc. CBLL recently announced that the FDA has granted Breakthrough Device Designation for its Large Vessel Occlusion ...

The Sunnyvale, CA-based firm's EEG-based solution uses artificial intelligence algorithms to identify large vessel occlusion ...

Ceribell announced today that the FDA granted breakthrough device designation for its large vessel occlusion (LVO) stroke ...

Roughly 25 percent of dementia patients were prescribed at least one ‘potentially inappropriate’ drug between 2013 and 2021 ...

Ceribell’s LVO Stroke tool is underpinned by the same EEG monitoring technology used in its seizure and delirium monitoring ...

Roughly 25 percent of dementia patients were prescribed at least one ‘potentially inappropriate’ drug between 2013 and 2021 ...

CNS-active drugs are associated with an increased risk of falls, delirium, and hospitalization. They are often prescribed for ...

Randal Alberto Gamboa-Esquivel suffered an “unspecified psychosis," the Department of Homeland Security told Newsweek.